HALO Halozyme Therapeutics, Inc.
$128.50▲ +0.38%
Healthcare
Other
After hours
$128.50▲ +0.00%
Oct 27, 4:00 PM ET
Volume 1.30M
Avg Volume (10D) 2.37M
Key Metrics & Fundamentals
Market Cap
$14.58B
P/E Ratio
37.6
Div Yield
0.00%
52W Range
61.23 - 128.66
% vs 50 MA
14.58%
% vs 200 MA
55.70%
RSI-14
76.6
MACD Histogram
+1.1200
Beta (1Y vs SPY)
0.51
Free Cash Flow
$236.72M
Gross Rev
$481.00M
Gross Profit
$401.83M
EBITDA
$321.62M
COGS
$79.17M
Operating Exp
$114.17M
Operating Income
$287.65M
EBIT
$287.65M
Pretax Income
$284.90M
Net Income
$229.91M
EPS (Diluted)
1.90
Price & Volume History
Loading chart…
Recent News
Strong Royalties and New Launches Accelerate Halozyme Therapeutics’ (HALO) Growth Momentum
Insider Monkey · Oct 27, 2026 7:32 AM ET
TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data
Zacks · Oct 26, 2026 10:41 AM ET
Incyte & Genmab Collaborate to Develop a New Colorectal Cancer Therapy
Zacks · Oct 26, 2026 10:25 AM ET
RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall
Zacks · Oct 26, 2026 10:17 AM ET
How Halozyme, Up Nearly 90% This Year, Is Rivaling Merck And Hitting New Highs
Investor's Business Daily · Oct 23, 2026 4:11 PM ET
BeOne Stock Tests Buy Zone With Visions Of 177% Earnings Growth. Watch This Clue.
Investor's Business Daily · Oct 23, 2026 1:50 PM ET
MRNA Tanks as Positive Phase III Cancer Therapy Data Fails to Impress
Zacks · Oct 23, 2026 11:08 AM ET
Incyte Gears Up to Report Q3 Earnings: Will Results Disappoint?
Zacks · Oct 23, 2026 8:25 AM ET
Halozyme to Report Third Quarter 2026 Financial and Operating Results
PR Newswire · Oct 22, 2026 8:30 AM ET
The Zacks Analyst Blog Highlights Chord Energy, Halozyme, Sezzle, SanDisk and Teradyne
Zacks · Oct 22, 2026 5:31 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HALO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.